Abstract:Background & aims: Autoimmune hepatitis (AIH) is characterized by hepatocyte destruction, leading to lymphocyte and macrophage accumulation in the liver. However, the specific mechanisms of how macrophages participate in the occurrence and development of AIH are still unclear. In this study, we investigated the effect of monocyte-derived macrophages on Con A-induced immunological liver injury in mice and we hypothesized that inhibition of CCR2 with the dual CCR2/5 inhibitor, cenicriviroc (CVC), would attenuate Con A-induced hepatitis in mice by reducing the recruitment of monocytes into the liver. Methods: Murine experimental AIH was established by concanavalin A (Con A) injection intravenously. Macrophages were depleted by injection of clodronate liposomes in Con A-treated mice. Moreover, inhibition of the CCR2/5 signaling pathway in Con A mice is achieved by CVC. Liver injury and infiltration of monocyte-derived macrophages were assessed by serum transaminase levels, histopathology, immunohistochemistry, flow cytometry, RT-qPCR, ELISA, TUNEL assay and dihydroethidium staining. Results: The number of macrophages in the mouse livers increased in the Con A-induced hepatitis mouse model, and flow cytometry showed a significant increase in the proportion of F4/80loCD11bhi monocyte-derived macrophages, while there was no significant change in the proportion of F4/80hiCD11blo Kupffer cells. After the depletion of liver macrophages by clodronate liposomes, the levels of serum ALT and AST, and the degree of liver tissue damage were alleviated in Con A-treated mice. Furthermore, Con A leaded an increase in the expression of a group of CC chemokines in mouse livers, and the elevation of CCL2 was prevented with the depletion of macrophages. Additionally, CVC reduced macrophage infiltration in the liver and ameliorated Con A-induced liver injury. Meanwhile, CVC reduced the apoptosis and oxidative damage of hepatocytes caused by Con A. Conclusions: Our research demonstrates that there is an increase in monocyte-derived macrophages in the livers due to the monocyte infiltration resulted from the activation of the CCL2-CCR2 axis in Con A-induced liver injury mouse model. Pharmacological inhibition of CCR2 monocyte recruitment by CVC efficiently ameliorates the hepatic inflammation, indicating the therapeutic potential of CVC in patients with AIH.

Upregulated Expression of Apoptosis-Associated Molecules in ConA-induced Liver Injury

The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A

The Protective Effect of Intrasplenic Transplantation of Ad-IL-18BP/IL-4 Gene-Modified Fetal Hepatocytes on ConA-induced Hepatitis in Mice.

Deactivation and apoptosis of hepatic macrophages are involved in the development of concanavalin A‑induced acute liver failure.

A Microarray Analysis of Early Activated Pathways in Concanavalin A-induced Hepatitis

Liver Injury in Mice Induced by ConA

The Fluctuation of Cytokine Mrna Expression Level of a Novel T-cell-mediated Immune Hepatic Fibrosis Model in Balb/c Mice

CD8+ T cell/IL-33/ILC2 axis exacerbates the liver injury in Con A-induced hepatitis in T cell-transferred Rag2-deficient mice

Pretreatment with a Low Dose of Concanavalin A Attenuated the Development of Concanavalin A-induced Hepatitis

Natural Killer T Cells Play a Necessary Role in Modulating of Immune-Mediated Liver Injury by Gut Microbiota

Tr1 Regulatory T Cells Induced by ConA Pretreatment Prevent Mice from ConA-induced Hepatitis.

The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.

Effect of TAK1 knockout in CD11c cells on concanavalin A-induced liver injury

Nature and Mechanisms of Hepatocyte Apoptosis Induced by D-galactosamine/lipopolysaccharide Challenge in Mice.

Hepatocyte-Derived Ig Kappa Exerts A Protective Effect Against Cona-Induced Acute Liver Injury

Selective Elimination of Hepatic Natural Killer T Cells with Concanavalin A Improves Liver Regeneration in Mice

Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis.

Pre-Activation of T Lymphocytes by Low Dose of Concanavalin A Aggravates Toll-Like Receptor-3 Ligand-Induced Nk Cell-Mediated Liver Injury

Comprehensive Immune Cell Analysis of Human Menstrual-Blood-derived Stem Cells Therapy to Concanavalin A Hepatitis

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

Monocyte-derived macrophages contribute to the deterioration of immunological liver injury in mice